Skip to main content
TipRanks
Go Ultimate75% OFF

Cutia Therapeutics (2487) Financial Statements

2 Followers

Cutia Therapeutics Financial Overview

Cutia Therapeutics's market cap is currently ¥256.08M. The company's EPS TTM is ¥-0.79; its P/E ratio is -0.73; Cutia Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 336.15M¥ 279.62M¥ 137.62M¥ 11.37M¥ 2.04M
Gross Profit¥ 195.79M¥ 143.46M¥ 71.01M¥ 7.94M¥ 1.61M
Operating Income¥ -308.61M¥ -455.15M¥ -539.65M¥ -309.20M¥ -179.99M
EBITDA¥ -265.23M¥ -416.98M¥ -1.92B¥ -535.19M¥ -309.23M
Net Income¥ -340.19M¥ -433.81M¥ -1.96B¥ -555.84M¥ -319.58M
Balance Sheet
Cash & Short-Term Investments¥ 789.16M¥ 876.15M¥ 1.27B¥ 1.08B¥ 1.38B
Total Assets¥ 1.31B¥ 1.39B¥ 1.71B¥ 1.45B¥ 1.49B
Total Debt¥ 317.53M¥ 320.94M¥ 243.75M¥ 54.13M¥ 26.53M
Net Debt¥ 51.82M¥ -64.73M¥ -229.37M¥ -411.74M¥ -176.60M
Total Liabilities¥ 405.08M¥ 418.51M¥ 357.76M¥ 2.69B¥ 2.29B
Stockholders' Equity¥ 885.66M¥ 974.73M¥ 1.35B¥ -1.25B¥ -790.51M
Cash Flow
Free Cash Flow¥ -302.97M¥ -468.66M¥ -437.23M¥ -371.50M¥ -185.76M
Operating Cash Flow¥ -290.09M¥ -442.98M¥ -381.31M¥ -236.19M¥ -159.88M
Investing Cash Flow¥ -20.28M¥ 316.07M¥ -203.58M¥ 462.06M¥ -410.65M
Financing Cash Flow¥ 193.03M¥ 37.84M¥ 588.32M¥ -10.25M¥ 480.76M

Currency in CNY

Cutia Therapeutics Earnings and Revenue History

-2.4B-1.2B01.2B-18000 %-12000 %-6000 %0 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin

Cutia Therapeutics Liabilities to Assets

01B2B3B0 %80 %160 %240 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets

Cutia Therapeutics Cash Flow

-500M-250M0250M500M750M20212022202320242025OperatingInvestingFinancing

Cutia Therapeutics Forecast EPS vs Actual EPS

-1-0.8-0.6-0.4-0.2Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss